Patent · US Active

Cyclic di-nucleotide compounds and methods of use

US11299512B2 · kind B2 · utility

0Cited by

21References

34Claims

0Family size

Assignees

ImmuneSensor Therapeutics, Inc. · US
The Board of Regents of the University of Texas System · US

Inventors

Boyu Zhong · Carmel, US
Heping Shi · Dallas, US
Yuanwei DAI · Dallas, US
Qi Wei · Dallas, US
Chuo Chen · Dallas, US
Zhijian Chen · Dallas, US
Lijun Sun · Harvard, US

Key dates

Filing date	Jun 11, 2019
Grant date	Apr 12, 2022
Priority date	—
Expiry date	Sep 22, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H21/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are cyclic-di-nucleotide cGAMP analogs, methods of synthesizing the compounds, pharmaceutical compositions comprising the compounds thereof, and use of compounds and compositions in medical therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.